Heron Therapeutics (NASDAQ:HRTX) reported its Q4 earnings results on Tuesday, March 12, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Heron Therapeutics beat estimated earnings by 56.00000000000001%, reporting an EPS of $-0.07 versus an estimate of $-0.16.

Revenue was up $4.21 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.12 which was followed by a 59.0% increase in the share price the next day.

Here's a look at Heron Therapeutics's past performance:

To track all earnings releases for Heron Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.